What about tilapia?
Tilapia are prone to intestinal infections by Coccidia and other protozoan and cryptosporidian intestinal parasites.
The symptoms appear when the fish are a few days old: they include lethargy, and a general secondary attack by fungal and viral infections that eventually kill the fish, making a diagnosis difficult.
Interestingly, neither the redbreast tilapia (Tilapia rendalli) nor the Nile tilapia (Oreochromis niloticus) is (as yet) afflicted by these parasites. In the Far East, Streptococcus has been the main tilapia disease in recent years. Most hatcheries simply live with it, as there is no vaccine.
Research into one is underway, however. Clean rearing conditions, regular removal of sick fish, and breeding of ‘strep-resistant’ strains are the only methods to contain outbreaks. Up to now, strep has rarely caused wholesale mortalities of tilapia under commercial rearing conditions.
Of more concern is Tilapia Lake Virus (TLV), which first appeared in Israel’s Lake Kinneret in 2009. Affecting both wild and farmed tilapia, the virus appears to be novel. It was only positively described as TLV in April this year.
In Israel, it affects the fish’s brain, making it swell and killing up to 80% of stocks. A TLV outbreak in Ecuadorian and Colombian fish farms affected the tilapia’s kidneys.
Closer to home is Epizootic Ulcerative Syndrome (EUS), a disease caused by the water mould Aphanomyces invadans. It infects many freshwater and brackish fish species in the East, but has also been identified more recently in stocks in the upper Zambezi and Congo systems.
The fish develop red spots and lesions on the skin that form ulcers and extensive erosions filled with necrotic tissue and mycelium. This is followed by damage to the internal organs and death. The disease affects several species of fish, including tilapia.
While the threat seems intimidating, the best preventative measures are straightforward: clean rearing conditions, reduced over-crowding, and lack of stress in culture facilities. Fingerlings should be sourced only from reputable hatcheries.
At this stage, government legislation will not help, as there is little or no capacity to identify such diseases. It needs to be developed – urgently.